Alexion announces makeover plans
On Sept. 12, Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) announced a restructuring plan aimed at streamlining costs while expanding its pipeline. The plan includes headcount reductions, facility closures, and the relocation of its headquarters to Boston, Mass. from New Haven, Conn.
Under the plan, Alexion will reduce global headcount by 600 (20%) over